Advance your translational research with fresh, high-quality human PBMCs that can be isolated to meet any study timeline requirements—including disease pain event-based and longitudinal collection from difficult-to-reach patient populations.
With Sanguine, you get high-quality, human PBMCs isolated from freshly collected whole blood or buffy coat—even from hard-to reach populations.
We isolate PBMCs from whole blood, ensuring high quality and cell viability. Using our standardized processing protocol, cryopreservation, and temperature-controlled shipments, we strive to deliver 90% post-thaw cell viability—making it practical to use the sample as is or isolate unique immune cells subsets, such as activated T cells.
A custom-tailored approach means an enhanced ability to recruit participants and procure biospecimens prospectively. You’ll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.
Longitudinal and event-based biospecimen and data collection
Same-day sample collection and delivery
Nationwide patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Long-term follow-up with study participants
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, International Conference on Harmonization (ICH) and Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 60,000 total members ready to advance science and medicine for the conditions they live with.